Search

• GSK data presented at ERS demonstrate potential of blood eosinophil levels to help inform COPD treatment decisions

  Media

  GSK presented data at ERS Congress showing blood eosinophil levels may help predict patients with COPD when receiving an ICS regimen.

  https://www.gsk.com/en-gb/media/press-releases/gsk-data-presented-at-ers-demonstrate-potential-of-blood-eosinophil-levels-to-help-inform-copd-treatment-decisions/

  First published: 08 September 2014

• GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business

  Media

  GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business

  https://www.gsk.com/en-gb/media/press-releases/gsk-reaches-agreement-with-novartis-to-acquire-full-ownership-of-consumer-healthcare-business/

  First published: 27 March 2018

• New long-term organ damage analysis published for GSK’s Benlysta® (belimumab)

  Media

  Patients with SLE are at risk of irreversible organ damage which will accrue over time and is associated with increased risk of death1.

  https://www.gsk.com/en-gb/media/press-releases/new-long-term-organ-damage-analysis-published-for-gsk-s-benlysta-belimumab/

  First published: 03 March 2016

• ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018

  Media

  Juluca, the first 2-drug regimen, once daily, single pill regimen, maintains viral suppression through 100 weeks.

  https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-sword-100-week-data-for-juluca-dolutegravirrilpivirine-at-aids-2018/

  First published: 24 July 2018

• Nucala (mepolizumab) approved in China for use in severe asthma with an eosinophilic phenotype

  Media

  Mepolizumab is the first targeted IL-5 biologic available in China as an add-on maintenance treatment for severe eosinophilic asthma.

  https://www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-approved-in-china-for-use-in-severe-asthma-with-an-eosinophilic-phenotype/

  First published: 10 January 2024

• 

  Codes, standards and reports

  Company

  Find out about our codes, standards and reports

  https://www.gsk.com/en-gb/company/codes-standards-and-reports/

  First published: 19 November 2024

• GSK and Theravance announce start of phase III lung function study with ‘closed’ triple combination treatment FF/UMEC/VI for COPD

  Media

  GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a second global phase III study

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-theravance-announce-start-of-phase-iii-lung-function-study-with-closed-triple-combination-treatment-ffumecvi-for-copd/

  First published: 09 February 2015

• GSK to divest ofatumumab for auto-immune indications to Novartis for up to $1 billion plus royalties

  Media

  GSK announced an agreement with Novartis Pharma to divest its rights in ofatumumab for auto-immune indications, incl. multiple sclerosis.

  https://www.gsk.com/en-gb/media/press-releases/gsk-to-divest-ofatumumab-for-auto-immune-indications-to-novartis-for-up-to-1-billion-plus-royalties/

  First published: 21 August 2015

• GSK announces NEJM publication of Phase 3b/4 study of ambrisentan and tadalafil as first-line combination treatment in patients with pulmonary arterial hypertension

  Media

  GSK today announced publication of first-line combination therapy of ambrisentan and tadalafil in treatment-naïve patients with PAH.

  https://www.gsk.com/en-gb/media/press-releases/gsk-announces-nejm-publication-of-phase-3b4-study-of-ambrisentan-and-tadalafil-as-first-line-combination-treatment-in-patients-with-pulmonary-arterial-hypertension/

  First published: 26 August 2015

• Comic Relief and GSK form five-year partnership to fight malaria and strengthen health systems

  Media

  A five-year partnership to fight malaria and improve health in five countries has today been launched by Comic Relief and GSK.

  https://www.gsk.com/en-gb/media/press-releases/comic-relief-and-gsk-form-five-year-partnership-to-fight-malaria-and-strengthen-health-systems/

  First published: 15 December 2015